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The ligands of the Bone Morphogenetic Protein (BMP) family of developmental signaling molecules are
often under the control of complex cis-regulatory modules and play diverse roles in vertebrate
development and evolution. Here, we investigated the cis-regulatory control of stickleback Bmp6. We
identiﬁed a 190 bp enhancer 2.5 kilobases 50 of the Bmp6 gene that recapitulates expression in
developing teeth and ﬁns, with a core 72 bp sequence that is sufﬁcient for both domains. By testing
orthologous enhancers with varying degrees of sequence conservation from outgroup teleosts in
transgenic reporter gene assays in sticklebacks and zebraﬁsh, we found that the function of this
regulatory element appears to have been conserved for over 250 million years of teleost evolution. We
show that a predicted binding site for the TGFb effector Smad3 in this enhancer is required for enhancer
function and that pharmacological inhibition of TGFb signaling abolishes enhancer activity and severely
reduces endogenous Bmp6 expression. Finally, we used TALENs to disrupt the enhancer in vivo and ﬁnd
that Bmp6 expression is dramatically reduced in teeth and ﬁns, suggesting this enhancer is necessary for
expression of the Bmp6 locus. This work identiﬁes a relatively short regulatory sequence that is required
for expression in multiple tissues and, combined with previous work, suggests that shared regulatory
networks control limb and tooth development.
& 2015 Elsevier Inc. All rights reserved.
Introduction
Bone Morphogenetic Protein (BMP) ligands, the largest sub-
family of TGFβ ligands, play multiple essential roles during
vertebrate development (Hogan, 1996; Kingsley, 1994; Massagué,
2012), including during craniofacial and tooth development (Nie
et al., 2006). Many vertebrate organs develop through reciprocal
permissive and instructive signaling between adjacent epithelial
and mesenchymal tissues, often involving multiple BMP ligands
(Bellusci et al., 1996; Dassule and McMahon, 1998; Dudley et al.,
1999; Jung et al., 1998). These pleiotropic functions of BMP ligands
are orchestrated by typically large, modular, regulatory regions,
which work together to drive complex spatiotemporally restricted
expression patterns (Pregizer and Mortlock, 2009).
In humans, regulatory variation in Bmp genes has been asso-
ciated with developmental disorders including brachydactyly and
other birth defects (Dathe et al., 2009; Justice et al., 2012), as well
as colorectal cancer (Houlston et al., 2008; Lubbe et al., 2012).
In other animals, variation in the expression of Bmp genes has
also been associated with major evolved changes in morphology,
including beak shape in Darwin's ﬁnches (Abzhanov et al., 2004),
jaw size and shape in cichlid ﬁsh (Albertson et al., 2005), and tooth
number in stickleback ﬁsh (Cleves et al. 2014).
While the cis-regulatory architecture of Bmp2, Bmp4, Bmp5, and
Bmp7 has been studied in mice (Adams et al., 2007; Chandler et al.,
2007; Guenther et al., 2008; Jumlongras et al., 2012), less is known
about Bmp6 and Bmp gene regulation in other vertebrates.
Although not required for viability in the mouse, Bmp6 is required
for axial skeletal patterning (Solloway et al., 1998), kidney function
(Dendooven et al., 2011), and physiological iron regulation
(Andriopoulos et al., 2009). Non-coding variants in human Bmp6
have been associated with human height variation (Gudbjartsson
et al., 2008; Wood et al., 2014), as well as orofacial clefting birth
defects (Shi et al., 2012). A cis-regulatory allele of stickleback Bmp6
with reduced Bmp6 expression in developing tooth tissue has
recently been shown to be associated with evolved increases in
tooth number in derived freshwater sticklebacks, likely adaptive
for the shift in diet in freshwater sticklebacks relative to their
marine ancestors (Cleves et al., 2014).
BMP signaling plays complex and, in general, poorly understood
roles during the development of placodes. During tooth develop-
ment, multiple Bmp genes are expressed dynamically in developing
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odontogenic epithelia and mesenchyme (Aberg et al., 1997; Vainio
et al., 1993). Several lines of evidence reveal BMP signaling plays
activating roles during odontogenesis. First, epithelial BMP4 activates
Msx expression in the mesenchyme, and exogenous BMP from a bead
(Bei and Maas, 1998; Chen et al., 1996) or transgene (Zhao et al., 2000)
can partially rescue tooth development in Msx1 mutant mice. Second,
in mice, teeth arrest at the bud-to-cap transition in Bmpr1a mutants
(Andl et al., 2004; Liu et al., 2005). Third, exogenous BMP4 beads can
induce molar development in mice (Kavanagh et al., 2007). Fourth, in
ﬁsh, pharmacological inhibition of BMP signaling can inhibit tooth
formation in cichlids (Fraser et al., 2013). In contrast, other evidence
supports BMP signaling playing inhibitory effects during the develop-
ment of teeth and other placodes. In mice, Pax9 expression marks
early dental mesenchyme, and BMP2 and BMP4 inhibit Pax9 expres-
sion (Neubüser et al., 1997). In zebraﬁsh, inhibition of BMP signaling
produces supernumerary teeth with altered morphology (Jackman
et al., 2013). During development of both feather and hair placodes,
BMPs play inhibitory roles (Botchkarev et al., 1999; Jung et al., 1998;
Mou et al., 2006, 2011), and suppression of epithelial BMP signaling is
required for hair placode induction (reviewed in Biggs and Mikkola,
2014). Together these results suggest that complex positive and
negative interactions between epithelial and mesenchymal BMPs are
critical for placode development, yet the regulation of these interac-
tions remains less well understood.
Despite the major role BMP signaling plays during tooth develop-
ment, little is known about the cis-regulatory sequences that drive
dynamic Bmp expression in early developing odontogenic epithelia and
mesenchyme. In mice, a late-stage ameloblast enhancer has been
identiﬁed for the Bmp4 gene (Feng et al., 2002); however this enhancer
is not reported to be active during embryogenesis, or in dental
mesenchyme. A second enhancer of mouse Bmp4 has been described
that is active during embryogenesis and drives expression in dental
epithelium but not mesenchyme (Jumlongras et al., 2012). Tooth
epithelial and mesenchymal enhancers of the mouse Bmp2 gene have
been localized to a 150 kb region 30 of Bmp2 (Chandler et al., 2007),
however these enhancers have not yet been further mapped, and in
general, cis-regulation of BMPs in dental mesenchyme is poorly under-
stood. Furthermore, sincemice are monophyodonts that form onewave
of primary teeth and no replacements, less is known about cis-
regulatory elements that drive expression in developing and replace-
ment teeth in polyphyodont vertebrates (such as ﬁsh) that replace their
teeth continuously. Because of the recently identiﬁed cis-regulatory
allele of Bmp6 associated with evolved changes in stickleback tooth
number (Cleves et al., 2014) and to dissect epithelial and mesenchymal
cis-regulation of vertebrate BMP signaling, we sought to begin to
identify the cis-regulatory architecture of the stickleback Bmp6 gene.
Methods
Animal statement and ﬁsh husbandry
All animal work was approved by the Institutional Animal Care
and Use Committee of the University of California–Berkeley (pro-
tocol number R330). Sticklebacks (Gasterosteus aculeatus) were
raised in 10% seawater (3.5 g/l Instant Ocean salt, 0.217 ml/l 10%
sodium bicarbonate) at 18 1C, and crosses were generated by
in vitro fertilization. Zebraﬁsh (Danio rerio) were raised in a
recirculating system under standard conditions, and embryos
were collected either from natural spawning or in vitro fertilization
and raised at 28.51 (Westerﬁeld, 2007).
BAC isolation and recombineering
Bacterial Artiﬁcial Chromosomes (BACs) from the CHORI-213 and
CHORI-215 (Salmon River marine and Paxton benthic freshwater
stickleback, respectively) BAC libraries were identiﬁed by overgo screen-
ing (Ross et al., 1999) using the following overgoes: 50- TGTGACGTT-
GACCTCAGCTAGACT-30 and 50–GAGGATTTAAACCGGGAGTCTAGC-30.
BAC ends were sequenced using Sp6 and T7 primers and
mapped to the stickleback genome using the UCSC browser. BAC
CHORI-215-29E12 was chosen for reporter analysis because Bmp6
was relatively centrally located in the BAC. Inverted Tol2 sites were
recombineered into the Lox511 site of the pTarbac2.1 backbone
according to Suster et al. (2011) using primers PTARBAC_tol2FWD
and PTARBAC_tol2REV, and ampicillin resistance was used to
select successfully recombineered BAC clones. To place GFP into
exon 1 of Bmp6 as a reporter, a GFP/kanamycin resistant cassette
was ampliﬁed from pGFP-FRT-Kan-FRT (Suster et al., 2011) using
primers GFP_Bmp6_for and GFP_Bmp6_rev (Table S1), which
contained 50 bp homology to the beginning and end of the ﬁrst
exon of stickleback Bmp6, respectively. This construct was then
recombineered into the BAC containing iTol2 sites to produce the
ﬁnal reporter BAC (see Fig. 6A–C).
Enhancer constructs
The vector for the stickleback 2.8 kb enhancer/promoter con-
struct was generated using pENTRbasGFP and pTolDest (Villefranc
et al., 2007) using Gateway cloning to produce a construct with the
carp ß-actin basal promoter (Scheer and Campos-Ortega, 1999)
upstream of EGFP, ﬂanked by Tol2 sites (Urasaki et al., 2006). Next,
a 2810 bp sequence upstream of the predicted Bmp6 transcrip-
tional start site was PCR ampliﬁed from BAC CHORI-213-256N24
using primers Gac_3 kb_for and Gac_3 kb_rev and cloned
upstream of the carp ß-actin promoter using a ClaI restriction site.
Blocks of conserved sequences within the 2.8 kb construct were
identiﬁed as CS1, CS2, and CS3 from the UCSC 8 species Multiz
conservation track (see Fig. 1A). These sequences were cloned into
ClaI site of the carp ß-actin reporter construct using primers
shown in Table S1. CS1 was cloned with Gac_3 kb_for and
Gac_CS1_rev. CS2 was cloned with Gac_CS2_for and Gac_CS2_rev.
CS3 was cloned with Gac_CS3_for and Gac_3 kb_rev. CS2þ3 was
cloned with Gac_CS2_for and Gac_3 kb_rev. Because the CS1
fragment drove weak expression with the ß-actin promoter, we
switched to using a well-characterized zebraﬁsh hsp70 promoter
construct, which we found to drive much brighter expression in
transgenic stickleback embryos. CS1 and CS2þ3 were also cloned
into the hsp70 promoter construct for additional testing using the
same genomic primer sequences but with Nhe and BamHI restric-
tion sites in place of ClaI. The 190 bp and 72 bp enhancer
sequences were ampliﬁed from the 2.8 kb construct with primers
indicated in Table S1 and cloned into the hsp70 construct.
The orthologous enhancer sequences were identiﬁed in other
teleost genomes using the UCSC genome browser (genome.ucsc.
edu) to identify sequence conservation. Zebraﬁsh and medaka
(Oryzias latipes) wild-type genomic DNA was isolated by standard
phenol-chlorofom extraction and enhancers were ampliﬁed using
primers (Table S1) designed from the respective genome assem-
blies (zv9/danRer7 and oryLat2) and cloned into the hsp70
promoter construct. The Atlantic cod (Gadus morhua) enhancer
DNA sequence was identiﬁed by sequence conservation on contig
CAEA01327401 of the Atlantic cod genome assembly (UCSC,
gadMor1). This short, unassembled contig is ﬂanked by repetitive
sequence, but the intervening sequence contains a 94 bp stretch
that has 92.4% sequence identity to the stickleback enhancer and is
likely the orthologous sequence. We synthesized a 130 bp con-
struct of Atlantic cod sequence by using two primers for ampliﬁ-
cation (Gmo_for and Gmo_rev, see Table S1) and two additi-
onal overlapping oligonucleotides as template (Gmo_temp1 and
Gmo_temp2). The template oligonucleotides were added to stan-
dard Phusion (NEB) PCR reaction at a concentration of 0.05 μM to
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amplify the full 130 bp sequence, which was then cloned into the
Tol2 construct as described above.
Sequence analysis
Sequence alignments were generated using ClustalW2 (http://
www.ebi.ac.uk/Tools/msa/clustalw2/) (Larkin et al., 2007) and Box-
shade (http://www.ch.embnet.org/software/BOX_form.html). Binding
sites were predicted with the UniProbe database (http://the_brain.
bwh.harvard.edu/uniprobe/) (Newburger and Bulyk, 2009) and
PROMO (http://alggen.lsi.upc.es/cgi-bin/promo_v3/promo/promoinit.
cgi?dirDB=TF_8.3) (Farre et al., 2003; Messeguer et al., 2002).
Imaging and microscopy
Transgenic lines were imaged using a Leica DM2500 compound
microscope equipped with a Leica DFC500 camera, a Leica M165FC
dissecting microscope equipped with a DFC340 FX camera, or a
Zeiss 700 confocal microscope. Transgenic ﬁsh were ﬁxed for 4 h
at 4 1C in either 4% paraformaldehyde in 1X PBS or 10% neutral
buffered formalin. For Alizarin red ﬂuorescent counterstaining of
GFP lines, 0.01% Alizarin red was added to the ﬁxative. Tooth
number was counted on the DM2500 with TX2 ﬁlter to visualize
Alizarin-stained teeth. Tooth germs with GFPþ epithelia were
counted on photographs of GFP ﬂuorescence.
Fish injections and line generation
Transposase mRNA was produced from the pCS2-TP plasmid
(Kawakami et al., 2004) with the mMessage mMachine SP6 in
vitro transcription kit (Ambion) according to manufacturer's
instructions and puriﬁed with a Qiagen RNeasy column. Zebra-
ﬁsh injections were performed with 25 ng/mL plasmid DNA
and 37.5 ng/mL transposase and 0.05% phenol red as previously
Fig. 1. A conserved 190 bp enhancer upstream of Bmp6 drives gene expression in several domains. (A) The 50 region of stickleback Bmp6 from the UCSC genome browser
(http://genome.ucsc.edu/). The region of genomic DNA used in the 2.8 kb enhancer construct (see Fig. S3) is shown in green, conserved sequences (CS) 1–3 are shown in
purple, and the subcloned 190 bp enhancer is shown in yellow. The ﬁrst exon and part of the ﬁrst intron of Bmp6 are shown in thick and thin black lines, respectively
(bottom). Conservation peaks and alignments (dark blue and gray) are shown from the 8-Species MultiZ track. (B) Zoom in on the middle of CS1, approximately 2.5 kb
upstream of the predicted Bmp6 transcription start site. The 190 bp enhancer, the 72 bp minimal enhancer (see Fig. S6), and a predicted Smad3 binding site (see Figs. 3 and 4)
are shown in yellow, pink, and blue, respectively. The conservation track is shown as dark blue peaks, above green alignments showing conservation to medaka, tetraodon,
fugu, and zebraﬁsh, from top to bottom. (C) GFP reporter expression pattern driven by the 190 bp enhancer in a 5 dpf (stage 22, (Swarup, 1958)) stickleback embryo. Strong
expression was seen in the distal edge of the developing pectoral ﬁn (arrow), the heart (asterisk), and the distal edge of the median ﬁn (arrowhead). (D) Confocal projection
of GFP reporter expression in the ventral pharyngeal tooth plate in a 10 mm stickleback fry. Expression was observed in the epithelium of developing tooth germs (arrow)
and the odontogenic mesenchyme (arrowhead) in the cores of ossiﬁed teeth. Bones are ﬂuorescently stained with Alizarin red. (E) GFP reporter expression in the oral teeth
(arrow) of a 30 dpf stickleback fry. GFP in the lens is an internal control for the zebraﬁsh hsp70 promoter used in the transgenic construct. Scale bars¼200 μm.
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described (Fisher et al., 2006). Because stickleback embryos are
much larger than zebraﬁsh embryos, the DNA and RNA concentra-
tions were increased to 37.5 and 75 ng/mL respectively. Stable
transgenic lines were generated by outcrossing injected ﬁsh to
non-transgenic ﬁsh and visually screening for ﬂuorescent trans-
genic offspring. At least two stable lines were observed for each
Fig. 2. Evolutionary functional conservation of the Bmp6 enhancer in teleosts. (A) Sequence alignments of four teleost sequences relative to the 190 bp stickleback enhancer. The
perfectly conserved Smad3 dimer binding site is marked in blue, and purple arrows mark the boundaries of the 72 bp minimal enhancer (see Fig. S6). (B-D) The stickleback sequence
reporter construct stably integrated into the zebraﬁsh genome drove expression in the distal edge of the median ﬁn at 24 hpf (arrow in B), the distal edge of the pectoral ﬁn at 48 hpf
(arrow in C), and tooth epithelium (arrow) and mesenchyme (arrowhead) at 5 dpf (D). (E-G) A 477 bp construct of zebraﬁsh genomic sequence centered around the conserved
sequence of the enhancer drove similar, but weaker expression in the median ﬁn of a 33 hpf zebraﬁsh (arrow in E), pectoral ﬁns of a 48 hpf zebraﬁsh (inset of F), and teeth of a 5 dpf
zebraﬁsh (G). (H-I) Although not detected in seven of eight stable lines, in one of eight stable lines, the zebraﬁsh sequence drove faint expression in the distal edges of the median ﬁn
(arrow in H) and pectoral ﬁns (arrow in I) of 5 dpf stickleback. However, no expressionwas detected in tooth germs in newly hatched fry in any line (J). See Table S2 for quantiﬁcation
of expression domains of transgenic lines. Bone is ﬂuorescently stained with Alizarin red in (D, G, J). Scale bars¼200 μm.
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construct to ensure ﬂuorescent patterns were due to the transgene
and not artifacts of the transgene integration sites.
Site directed mutagenesis
Mutagenesis primers were designed using the online Quickchange
tool (http://www.genomics.agilent.com/primerDesignProgram). For
constructs containing multiple mutations, the mutagenesis was per-
formed in multiple rounds. Mutagenesis reactions were performed
with 125 ng of each primer, 50 ng plasmid template, 200 μM dNTPs,
and Pfu Turbo polymerase and buffer. Cycling conditions were 95 1C
for 30 s, followed by 16 cycles of 95 1C / 30 s, 55 1C / 60 s, and 68 1C
/780 s. Primer sequences can be found in Supplementary Table 1; the
mutated sequences are shown in Fig. 3A. DpnI was added immediately
after cycling, and the reaction was incubated for 1 h at 37 1C, then
immediately transformed into Top10 chemically competent E. coli cells.
Drug treatments
SB431542 and XAV939 (Sigma) were dissolved in DMSO to
concentrations of 100 mM and 10 mM, respectively. The drug was
then diluted into stickleback water or zebraﬁsh system water to
working concentrations (25-100 mM for SB431542 and 5–10 mM for
XAV939). A DMSO vehicle control was done in parallel with all
drug treatments. Drug treatment was performed in 6- or 24-well
cell culture dishes. Sticklebacks were treated from 2 dpf to 5 dpf
for observation of pectoral and median ﬁn expression, and for 5–7
days post-hatching for observation of tooth GFP. Zebraﬁsh were
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Wild-type        GCGCTCGCTTGAAAAGAGAGCGATTCAAGCAGACAAAGACCTCATTAGGTCTAGGAGGTGTCCT
Homeodomain      GCGCTCGCTTGAAAAGAGAGCGATTCAAGCAGACAAAGACCggggTAGGTCTAGGAGGTGTCCT
PEA3            GCGCTCGCTTGAAAAGAGAGCGATTCAAGCAGACAAAGACCTCATTAGGTCTAGGAGGTGTCCT
RAR-gamma        GCGCTCGCTTGAAAAGAGAGCGATTCAAGCAGACAAAGACCTCATTAGGTCTAGGAGGTGTCCT
TCF/Lef          GCGCTCGCTTGAAAAGAGtcCGATTCAAGCAGAtgcgGACCTCATTAGGTCTAGGAGGTGTCCT
Smad3            GCGCTCGCTTGAAAAGAGAGCGATTCAAGCAGACAAAGACCTCATTAGGTCTAGGAGGTGTCCT
Zebrafish:                                 *    * **    *   **  * * *   **    **
Wild-type        GTCTAGACAGTGTGATGACAGGACACAGAACCTCTGTTTAATGTTTCCTCCTCCTCCCTCTACT
Homeodomain      GTCTAGACAGTGTGATGACAGGACACAGAACCTCTGTTTAATGTTTCCTCCTCCTCCCTCTACT
PEA3             GTCTAGACAGTGTGATGACAGGACACAGAACCTCTGTTTAATGTTTttTCCTCCTCCCTCTACT
RAR-gamma        GTCTAGACAGTGTGATGACAGGACACAGAACCTCTGTTTAATGTTTCCTCCTCCTCCCTCTACT
TCF/Lef          GTCTAGACAGTGTGATGACAGGACACAGAACgaCTGTTTAATGTTTCCTCCTCCTCCgaCTACT
Smad3  tttTAtttAGTGTGATGACAGGACACAGAACCTCTGTTTAATGTTTCCTCCTCCTCCCTCTACT
Zebrafish:       **********  ***********     *   ****** * **   ****   * * * *   *
Wild-type        TCCAATTCACCCGCCGAACACACACATCACCTGCTCTGCCTCCAGGGATGTGCGCAAACACA
Homeodomain      TCCAATTCACCCGCCGAACACACACATCACCTGCTCTGCCTCCAGGGATGTGCGCAAACACA
PEA3            TttAATTCACCCGCCGAACACACACATCACCTGCTCTGCCTCCAGGGATGTGCGCAAACACA
RAR-gamma        TCCAATgggCCCGCCGAACACACACAgggCCTGCTCTGCCTCCAGGGATGTGCGCAAACACA
TCF/Lef          TCCAATTCACCCGCCGAACACACACATCACCTGCTCTGCCTCCAGGGATGTGCGCAAACACA
Smad3            TCCAATTCACCCGCCGAACACACACATCACCTGCTCTGCCTCCAGGGATGTGCGCAAACACA
Zebrafish:           *  *** *  *    *  *   *  *        * *   *     **     *  **
Fig. 3. Mutations in a predicted Smad3 binding site severely reduce enhancer function. (A) Binding sites predicted by UniProbe and PROMO are highlighted with a unique
color for each signaling pathway. Highlighted sequences represent the “predicted sequence” from PROMO or the “K-mer” from UniProbe. Mutated base pairs are shownwith
lowercase letters. Nucleotide positions conserved to zebraﬁsh are indicated with an asterisk, and arrows indicate the 72 bp minimal enhancer sequence. (B-C) Sticklebacks
were injected with each mutated construct and scored for pectoral ﬁn and/or median ﬁn expression at 5 dpf (B) and oral and/or pharyngeal tooth expression at 12–13 dpf (C).
Frequency of expression in these domains is shown as a percentage of the total number of GFP-positive ﬁsh (scored as GFP expression driven by the hsp70 promoter
anywhere at 5 dpf or in the lens at 12–13 dpf) on the y-axis.
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treated beginning at 10 hpf for observation of median ﬁn and
beginning at 24 hpf for pectoral ﬁn and tooth expression. For
multiday treatments, fresh solution was applied every 48 h until
the end of the experiment.
In situ hybridization (ISH)
Bmp6 in situ hybridization was performed on embryos and
newly-hatched juveniles as previously described (Cleves et al.,
2014). For pharyngeal tooth and gill ISH, the branchial skeleton
was dissected out of the embryo and cut along the dorsal midline
prior to the hybridization step.
Mutagenesis using TALENs
TAL Effector Nucleases (TALENs) were targeted to the predicted
Smad3 binding site within the 190 bp enhancer using TAL Effector
Nuclear Targeter 2.0 (https://tale-nt.cac.cornell.edu/) using the
Cermak architecture (Cermak et al., 2011; Doyle et al., 2012). TALEN
plasmids were generated using the RVDs shown in Table S4. TALEN
Fig. 4. Pharmacological disruption of TGFβ signaling or TALEN-induced mutations of the predicted Smad3 binding site reduce enhancer activity. (A–C) Treatment of
stickleback fry for 7 days in SB431542 (an ALK5 inhibitor) severely reduced GFP expression driven by the 190 bp enhancer in a dose-dependent manner. Expression was
severely reduced in the epithelia (arrows), but not mesenchyme (asterisks), of pharyngeal teeth at both low (25 μM, B) and high (50 μM, C) doses relative to controls (A).
(D-F) SB431542 also eliminated GFP driven by the stickleback enhancer in a zebraﬁsh trans environment. (G) The sequence targeted by TALENs contains a predicted Smad3
homodimer binding site (blue). The TALEN binding sites are indicated in purple text and the purple scissors indicate the approximate site of endonuclease activity. The XbaI
site used for molecular screening is underlined in green, and the mutagenized sequence of the Smad3 binding site, indicated by orange letters, is shown below. (H-I) Injection
of the TALENs into stable transgenic ﬁsh carrying the 190 bp reporter construct resulted in near complete loss of GFP expression in 95% of injected animals (I) relative to
controls (H). Residual GFP seen in (I) is likely the result of the mosaicism of TALEN-induced lesions. (J). Mutating the predicted Smad3 binding site resulted in a loss of GFP
expression in both epithelium and mesenchyme of pharyngeal teeth in 3/3 stickleback lines observed. Bone is ﬂuorescently counterstained with Alizarin red. Scale
bars¼200 μm.
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mRNAs were produced with the Mmessage Mmachine kit (Ambion),
puriﬁed with Qiagen RNeasy columns, and injected into one-cell
stickleback embryos at a concentration of 40 ng/mL for each mRNA
plus 0.05% phenol red. Embryos and juvenile ﬁsh were screened for
lesions in the Smad3 site by screening for loss of an XbaI cut site in a
144 bp PCR product ampliﬁed with primers Gac_190_for and
Gac_72_rev (see Fig. 4G). F1 animals with deletions visible on a 2%
agarose gel (15 bp or larger) were crossed to generate animals used
in in situ hybridization. Because the F1 parents carried different
TALEN-induced lesions, the F2 animals used for ISH were transheter-
ozygotes for two slightly different alleles of the enhancer deletion
(see Fig. 6E).
Results
A Bmp6 reporter BAC recapitulates endogenous Bmp6 expression
To begin to identify the cis-regulatory architecture of the
stickleback Bmp6 gene, we generated a Bmp6 reporter line by
identifying a bacterial artiﬁcial chromosome (CHORI BAC215-
29E12) containing 180 kb of sequence starting 52 kb upstream
of Bmp6. Inverted Tol2 sequences were recombineered into the
backbone of this BAC, and the ﬁrst exon of Bmp6was replaced with
GFP coding sequence. This transgenic construct drove GFP repo-
rter expression in a variety of tissues throughout development
(Fig. S1), including the embryonic tailbud following somitogenesis
(3.5 dpf), the embryonic heart and ventrolateral cells in the
pharyngeal region (4 dpf), the distal edge of the developing
pectoral ﬁn, and the distal edge of the median ﬁn (5 dpf). After
hatching (10–15 dpf), expression was seen in oral and pharyngeal
teeth, the pericardium, cells surrounding the opercle and bran-
chiostegal rays, gill buds, and gill rakers.
We compared this transgene expression pattern to the expres-
sion pattern of endogenous Bmp6 mRNA via in situ hybridization.
We observed Bmp6 expression in nearly all of the same domains as
the reporter BAC (Fig. S2), including the tailbud (at 3.5 dpf), heart,
the distal edges of the median and pectoral ﬁns (at 5 dpf), gills, gill
rakers, and in the previously described (Cleves et al., 2014)
epithelium and mesenchyme of developing teeth (assayed at
12 dpf). However, several domains observed by in situ hybridi-
zation were not observed in the BAC transgenic line, including the
notochord, the dorsal medial diencephalon, the eyes, and the ears
(Fig. S2), suggesting that regulatory elements lying outside of the
180 kb of genomic sequence contained within the BAC control
these Bmp6 expression domain.
A conserved 190 bp enhancer drives tooth, median ﬁn, and pectoral
ﬁn expression in both stickleback and zebraﬁsh
To begin to identify regulatory elements contained within this
180 kb genomic interval containing Bmp6, we ﬁrst cloned a
construct containing 2.8 kb of sequence immediately upstream
of stickleback Bmp6 containing regions of sequence conserved
among other teleosts (Fig. 1A). This construct drove GFP expres-
sion in a number of tissues that were similar to expression
patterns driven by the BAC (Fig. S3, compare to Fig. S1), including
the tailbud, the heart, pectoral and median ﬁns, oral and phar-
yngeal teeth, gills, and the pericardium. Other domains driven by
the BAC were not observed in the 5' construct, including gill
rakers, opercle, and branchiostegal rays; these domains are likely
driven by more distal regulatory elements contained within the
BAC but excluded from the 2.8 kb sequence. Combined, these
results suggest that much of the regulatory information for Bmp6
is contained within the 2.8 kb upstream sequence, but that other
regulatory elements drive additional expression domains.
We hypothesized that the different anatomical sites of expression
driven by the 2.8 kb fragment result from multiple anatomically
speciﬁc enhancers within this sequence. We ﬁrst tested three non-
overlapping subclones, each containing a block of evolutionarily
conserved sequence (Fig. 1A). While the most 50 subclone (CS1) drove
robust reporter gene expression in most domains of the 2.8 kb
fragment, neither the middle (CS2) nor 30 subclone (CS3) drove
detectable GFP expression in ﬁns, teeth, or other domains driven by
the 2.8 kb fragment at the 3–5 dpf or post-hatching (10–13 dpf) stages.
Furthermore, a construct containing CS2þCS3 also drove no detect-
able pattern of GFP with either the ß-actin or hsp70 promoter. Next,
we focused on the 50-most region (CS1), and tested a 190 bp fragment
highly conserved within teleosts (Fig. 1B). This 190 bp fragment drove
robust GFP expression in the distal edges of the pectoral and median
ﬁns, and oral and pharyngeal teeth (Fig. 1C–E). Within developing
teeth, GFP expression was observed in the inner dental epithelium
(IDE) for all constructs (Fig. S4) as well as the interior mesenchyme of
mature functional teeth (Fig. 1D), similar to endogenous Bmp6
expression during tooth development (Cleves et al., 2014). Robust
tooth GFP expression was seen in all teeth at all stages examined
including in juveniles and adults, suggesting tooth enhancer activity is
present in both primary and replacement teeth (Fig. 1D–E, data not
shown). Some domains, including the gills, were lost when CS1 was
reduced to the 190 bp fragment, suggesting that ﬂanking sequence is
required for these domains. When the orientation of the enhancer was
ﬂipped with respect to the hsp70 promoter, 77% (38/49) of injected
ﬁsh had pectoral and/or median ﬁn expression at 5 dpf, and 69% (27/
39) had oral and/or pharyngeal tooth expression at 13 dpf. This result
suggests that this enhancer functions regardless of orientation to the
promoter. Combined, our results suggest that most domains driven by
the 2.8 kb enhancer are driven by the short 190 bp conserved
sequence. This 190 bp minimal sequence does not differ between
marine and freshwater sticklebacks, though several marine-freshwater
sequence differences exist in the surrounding sequences of CS1.
Conservation of cis regulatory elements and trans machinery
in teleosts
Because we used evolutionary sequence conservation to iden-
tify the 190 bp minimal enhancer and the sequence was partially
conserved to zebraﬁsh, we hypothesized that this 190 bp stickle-
back enhancer would show similar activity in transgenic zebraﬁsh.
Stickleback and zebraﬁsh are 250 million years divergent (Near
et al., 2012) and share only 3 short blocks (totaling 28 bp, Fig. 2A)
of perfectly conserved nucleotides in the middle of the enhancer.
However, the stickleback enhancer robustly drove a highly similar
expression pattern in zebraﬁsh, with expression in the distal edges
of the median and pectoral ﬁns, and pharyngeal tooth epithelium
and mesenchyme (Fig. 2B–D), suggesting that the trans factors
activating the enhancer are conserved in distantly related teleosts.
We next asked whether the orthologous sequence from the
zebraﬁsh genome had similar enhancer activity in both zebraﬁsh
and sticklebacks. A construct containing 477 bp of sequence from
the orthologous region of the zebraﬁsh genome drove weak
expression in these expression domains (distal edges of median
and pectoral ﬁns, and teeth) in a subset of transgenic zebraﬁsh
offspring obtained (Fig. 2E–G and Table S2). In sticklebacks, seven
stable transgenic lines with the zebraﬁsh sequence driving GFP
had no ﬁn expression, although one transgenic line displayed very
faint expression in the distal edges of the median and pectoral ﬁns
(Fig. 2H–I). None of the eight lines had GFP expression in teeth
(Fig. 2J). Therefore, sticklebacks and zebraﬁsh likely share the trans
machinery sufﬁcient to drive expression from the stickleback
sequence, but the cis regulatory information present in the
zebraﬁsh orthologous sequence is not sufﬁcient to drive tooth
expression in the stickleback trans environment.
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Because the zebraﬁsh enhancer shows much less sequence
conservation to sticklebacks relative to other teleosts (Fig. 2A), we
hypothesized that the loss of robustness and loss of tooth expres-
sion may be unique to the zebraﬁsh cis-regulatory element. We
generated constructs containing the orthologous enhancer
sequences of a beloniform (medaka) and a gadiform (Atlantic
cod), which fall between zebraﬁsh and sticklebacks in the teleost
phylogeny (Near et al., 2012). We found that sequences from both
additional species drove expression in ﬁns and teeth in both
stickleback and zebraﬁsh embryos (Fig. S5, Table S2), although
the cod enhancer appeared to be slightly less robust (Table S2).
Based on the apparent partial conservation of enhancer function in
zebraﬁsh and the conserved activities of the medaka and cod
enhancers, we further shortened the stickleback enhancer to contain
the sequence most highly conserved among teleosts, a 72 bp sequence
near the center of the 190 bp construct, and hypothesized that it
would drive the tooth, median ﬁn, and pectoral ﬁn expression
domains. In support of this hypothesis, this construct in a stable line
of zebraﬁsh was sufﬁcient to drive strong GFP expression in teeth and
median and pectoral ﬁns (Fig. S6). Notably, the heart domain driven by
this construct was considerably brighter relative to the 190 bp
enhancer, suggesting that this short sequencemay have lost additional
repressor elements that limit expression in the heart. A similar pattern
of brighter heart expression was observed in stickleback injected with
this construct compared to the 190 bp larger construct (data not
shown). These results suggest that the ﬂanking conserved sequences
are not required for the basic enhancer pattern in ﬁns and teeth, but
may be important for ﬁne-tuning the transcriptional output.
A predicted Smad3 binding site is required for enhancer function
To identify candidate transcription factor binding sites within
the 190 bp enhancer, we used UniProbe and PROMO (Newburger
and Bulyk, 2009; Farre et al., 2003; Messeguer et al., 2002) and
found predicted binding sites of transcription factors in several
signaling pathways involved in developmental regulation: FGF
(PEA3), retinoic acid (RAR-γ), Wnt (TCF/Lef), and TGFβ (Smad3), as
well as a predicted homeodomain binding site (Fig. 3A). We were
particularly interested in the homeodomain binding site given the
known crosstalk between the Msx1 and Bmp4 genes during mouse
tooth development (Bei and Maas, 1998; Chen et al., 1996;
Jumlongras et al., 2012), and the predicted TCF/Lef sites, given
the previously described roles of Wnt signaling regulating Bmp4
dental mesenchyme expression in mice (Fujimori et al., 2010;
O’Connell et al., 2012). We quantiﬁed the number of stickleback
embryos showing pectoral and/or median ﬁn, as well as phar-
yngeal and/or oral tooth expression, when injected with con-
structs containing mutated binding sites. The mutation of TCF/Lef
and Smad3 binding sites signiﬁcantly decreased the percentage of
ﬁsh with median and/or pectoral ﬁn expression domains, whereas
the predicted PEA3, RAR-γ, and homeodomain mutations did not
(Fig. 3B). Likewise, only the mutations in predicted TCF/Lef and
Smad3 sites affected tooth expression, with especially reduced
expression when the predicted Smad3 binding site was mutated
(Fig. 3C). We made stable zebraﬁsh lines for each of the Smad3 and
TCF/Lef mutated enhancers and found that the Smad3-mutated
reporter construct did not drive robust expression in zebraﬁsh ﬁns
or teeth, while the TCF/Lef mutated construct did drive these
domains, albeit at apparently reduced levels (Fig. S7). Since the
Smad3-mutated construct did not drive ﬁn or tooth expression in
zebraﬁsh, we generated a stable line in sticklebacks and found that
this line similarly did not drive detectable median ﬁn, pectoral ﬁn,
or tooth expression (Fig. 4J). Therefore, the predicted Smad3 site is
required for normal enhancer output, while TCF/Lef sites may be
responsible for expression level but not tissue speciﬁcity.
A small molecule inhibitor of TGFβ signaling, but not a small molecule
inhibitor of Wnt signaling, abolishes enhancer function
Since the predicted Smad3 binding site was necessary for
enhancer function, we hypothesized that reducing TGFβ signaling
(mediated by Smad3) would result in a loss of expression driven by
the enhancer. To pharmacologically inhibit TGFβ signaling, we
treated transgenic sticklebacks and zebraﬁsh embryos with
SB431542, a speciﬁc inhibitor of ALK4/5 phosphatase activity that
abrogates TGFβ signaling in zebraﬁsh (Inman et al., 2002; Sun et al.,
2006). After 6 days of treatment in sticklebacks, GFP expression
driven by the 190 bp enhancer was reduced in a dose-dependent
manner in the epithelium, but not mesenchyme, of developing
pharyngeal teeth, with tooth epithelial expression abolished at
50 μM and reduced at 25 μM (Fig. 4A –C). Tooth mesenchymal
expression was slightly diminished at 50 μM and apparently unaf-
fected at 25 μM. Similarly, GFP reporter expression was lost in the
pharyngeal teeth of newly hatched zebraﬁsh upon treatment with
SB431542 from 24 hpf until 5 dpf (Fig. 4D–F). In sticklebacks, we also
saw a reduction, but not complete loss, of pectoral and median ﬁn
expression driven by the transgene upon treatment with SB431542
(Fig. S8), while the reductionwas more severe in the ﬁns of zebraﬁsh.
Combined with our site-directed mutagenesis of the Smad3 binding
site result, these pharmacological data suggest that TGFβ signaling
mediated by ALK4/5 (likely signaling via Smad3 binding) is necessary
for tooth epithelium enhancer activity. However other signals likely
contribute to the expression in the pectoral and median ﬁns and
tooth mesenchyme, as drug treatment did not completely abolish
these expression domains in sticklebacks.
Since the mutation of TCF/Lef binding sites appeared to
decrease enhancer activity in sticklebacks and zebraﬁsh (Fig. 3,
Fig. S7), we hypothesized that Wnt signaling might be an addi-
tional input into the 190 bp Bmp6 enhancer. To test this hypoth-
esis, we treated transgenic ﬁsh with SB431542, XAV939 (a speciﬁc
inhibitor of the Wnt signaling pathway that is active in zebraﬁsh
(Huang et al., 2009)), or both drugs in combination at low and high
doses. Treatment with a high-dose combination of XAV939 and
SB431542 decreased the standard length of ﬁsh (data not shown),
possibly indicating a slight developmental delay. With XAV939 or
SB431542 treatment alone, there was no effect of the drug on
tooth number, suggesting that neither drug alone arrests tooth
development. However, the two drugs in combination signiﬁcantly
reduced ventral pharyngeal tooth number (Fig. 5H), including at
the low dose that did not affect ﬁsh standard length, suggesting
that XAV939 is bioactive in sticklebacks and that reducing Wnt
and TGFβ signaling together disrupts tooth development.
There was no obvious qualitatively detectable effect of XAV939
treatment on the intensity of enhancer expression in the teeth, either
alone or in combination with SB431542 (Fig. 5; compare D and E to A,
and compare F and G to B and C). However, tooth mesenchymal GFP
in the combined drug treatment appeared slightly lower than with
SB431542 treatment alone (insets of Fig. 5). Importantly, we never saw
a complete loss of mesenchymal GFP with any drug treatment, but
frequently saw complete loss of epithelial GFP with SB431542 treat-
ment. To quantify the effect of drug treatment on epithelial GFP
expression, we counted the number of GFPþ tooth epithelia (regard-
less of ﬂuorescent intensity) in each treatment and expressed it as a
ratio to the total number of Alizarin red-stained teeth. XAV939 had no
effect on the relative number of GFPþ epithelia, while SB431542 had a
strong, dose-dependent effect (Fig. 5I). In combinationwith SB431542,
there was no additional effect of XAV939 on reporter expression
(GFPþ epithelia in the combination treatments did not differ from
treatment with SB431542 alone). Combined, our results suggest that
SB431542, but not XAV939, affects enhancer activity and that
simultaneous inhibition of Wnt and TGFβ signaling affects tooth
development.
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The 190 bp enhancer is necessary for Bmp6 expression
As an additional test of the importance of the predicted Smad3
binding site, we generated a pair of TALENs designed to induce
mutations in this region of the enhancer (see Fig. 4G). This pair of
TALENs was highly efﬁcient at producing lesions, detected molecularly
by loss of an XbaI restriction site, and conﬁrmed by Sanger sequencing
in a subset of individuals (Table S3; example deletions shown in
Fig. 6E). Upon injection of these TALENs into a stable transgenic line of
the 190 bp enhancer driving GFP, 95% of animals (40 of 42) showed
partial or full loss of GFP ﬂuorescence in the pectoral ﬁns and median
ﬁn expression at 5 dpf. In those same animals, 95% of animals (39 of
41) also showed partial or complete loss of oral and/or pharyngeal
tooth expression at 12–13 dpf (see example in Fig. 4I). Thus, the
lesions generated by these TALENs are highly effective at disrupting
activity driven by this 190 bp enhancer.
We next tested whether the sequence targeted by the TALENs was
necessary for Bmp6 expression by injecting the TALENs into a stable
transgenic line of the Bmp6:GFP BAC reporter. 91% (61/67) of animals
had a reduction or complete loss of pectoral and median ﬁn expres-
sion, and 89% (8/9) of dissected tooth plates showed severe reductions
of GFP expression in the pharyngeal teeth (representative animals
shown in Fig. 6 F–K). Notably, GFP expression in the embryonic and
juvenile heart was detectable at seemingly unaffected levels in all
animals, suggesting that the enhancer is not necessary for this
expression domain. Additionally, gill expression appeared to be
reduced but not completely eliminated in all animals observed
(n¼6), and gill raker expression was only slightly reduced. These data
suggest the enhancer is required for some (e.g. pectoral ﬁn, median ﬁn,
tooth epithelium), but not all domains of Bmp6 expression.
Next, we tested the role of the enhancer in driving endogenous
Bmp6 expression by performing in situ hybridization for Bmp6 in
ﬁsh trans-heterozygous for different TALEN-induced mutations in
the predicted Smad3 binding site (Fig. 6E). In these trans-hetero-
zygous ﬁsh, expression of Bmp6 was dramatically reduced in ﬁns,
tooth epithelia and gills, but gill raker expression appeared similar
Fig. 5. Wnt signaling is not required for enhancer function, but Wnt and TGFβ are required for tooth development. Newly hatched stickleback fry were treated with DMSO
(control, A), SB431542 (B–C), XAV939 (D–E), or a combination of the two drugs at low (25 μM for SB431542 and 5 μM for XAV939, F) or high (50 mM for SB431542 or 10 mM
XAV939, G) doses for 5 days. Main panels show Alizarin red and GFP for the ventral tooth plate; insets show GFP only for mesenchyme of a single tooth from the dorsal tooth
plate. (B, C) SB431542 reduced GFP in tooth epithelia (arrows) relative to control (A, and see Fig. 3). However, mesenchymal GFP (arrowhead, inset) was less severely reduced.
(D, E) XAV939 alone did not affect GFP expression in epithelia (arrows) or mesenchyme (arrowheads) at either dose. (F, G) No strong additional effect on GFP expression was
seen when XAV939 and SB431542 were combined, though mesenchymal GFP appeared slightly lower in the combined dose. (H) A combination of SB431542 and XAV939
signiﬁcantly reduced ventral pharyngeal tooth number. (I) Treatment with SB431542, but not XAV939, decreased the number of green tooth epithelia relative to total ventral
teeth (ratio is expressed as a decimal). XAV939 had no additional effect on green epithelia in combination with SB431542. Tukey HSD P-values of relevant comparisons are
shown above with asterisks (n¼Po0.05, nn ¼Po0.0005, n.s.¼P40.05). Scale bars¼200 μm.
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to wild-type controls (Fig. 6L–Q). Despite the severe loss of Bmp6
expression in tooth epithelia in mutant ﬁsh, expression in the
mesenchyme of developing teeth was still detectable, although at
apparently reduced levels (Fig. 6N–O). Thus, this enhancer is
required to maintain normal levels of Bmp6 expression in devel-
oping ﬁns and tooth epithelia.
TGFβ signaling is necessary for normal Bmp6 expression levels
Since enhancer activity was lost upon treatment with a TGFβ
inhibitor, and the enhancer is required for normal Bmp6 expression,
we predicted that endogenous Bmp6 expression would likewise be
reduced upon inhibition of TGFβ signaling. By in situ hybridization,
Fig. 6. The 50 190 bp enhancer is necessary for Bmp6 expression. (A) Schematic of the genomic location of the 180 kb CHORI BAC29E12 with respect to Bmp6 and nearby
genes (coding regions shown in black are Ipo4, Pdcd6, Txndc5, Muted, Eef1e1, and Slc35b3 from left to right). (B) Recombineering strategy for introducing GFP into the ﬁrst
exon of Bmp6; gray bars indicate exons. (C) Final circular BAC with inverted Tol2 sites for transposition and GFP reporter (not to scale). (D) Strategy for introducing TALEN
lesions into the 190 bp 50 enhancer. The same TALENs were used to target the enhancer in stable transgenic BAC ﬁsh and at the endogenous Bmp6 locus (diagram not to
scale). (E) Sequences of stable mutant enhancer alleles. For the endogenous locus targeting, F2 ﬁsh trans-heterozygous for two different enhancer mutations were generated.
Fish in (M) carried alleles 1 and 2; ﬁsh in (O) and (Q) carried alleles 1 and 3. The predicted Smad3 binding site is indicated with blue text in the wild type sequence. (F, G) In
the reporter BAC, TALEN injection frequently severely reduced GFP expression from the pectoral ﬁn relative to controls at 5 dpf. A small patch of mosaic, unaffected GFP is
indicated with the arrow in (G). (H, I) TALEN injection also eliminated much of the Bmp6 tooth expression (I). (J, K) GFP expression was also reduced in gills (asterisk) and
slightly reduced in the gill rakers (arrowhead). (L-M). Mutations in the enhancer caused a reduction in pectoral ﬁn expression relative to wild-type siblings. (N, O) Bmp6
expression was also lost in tooth epithelia (arrows), but was not entirely lost in mesenchyme (arrowheads). (P, Q) Expression was also noticeably reduced in gills (asterisk),
though gill raker expression (arrows) appears similar to wild-type sibling controls. Scale bars¼100 μm.
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pectoral ﬁn and tooth epithelium expression of Bmp6 were both
reduced upon 100 mM SB431542 treatment (Fig. 7A–D). SB431542
treatment also reduced GFP expression in reporter BAC animals in
ﬁns and teeth (Fig. 7E–H). The effect of the drug on BAC-driven GFP
was not robustly observed with a 50 mM treatment (data not
shown), despite the strong effect that this dose had on enhancer
expression (Fig. 4). Together these data support a model in which
TGFβ signaling is required for Bmp6 expression in teeth and ﬁns and
exerts its effect through the putative Smad3 binding site that is
necessary for enhancer function.
Discussion
A short, conserved enhancer with pleiotropic expression domains
required for Bmp6 tooth and ﬁn expression
Here we have identiﬁed a 190 base pair enhancer that is highly
conserved in teleosts and is both necessary and sufﬁcient for tooth and
ﬁn expression of stickleback Bmp6. Site-directed mutagenesis of a
predicted Smad3 binding site and pharmacological experiments
suggest this enhancer is TGFβ-responsive. Though this enhancer drives
expression in several of Bmp6's endogenous domains, our results
suggest that like other Bmp genes, stickleback Bmp6 contains a
complex cis-regulatory architecture composed of multiple modules
driving expression in different domains. We detected embryonic
expression domains of Bmp6 by in situ hybridization, such as the
eye, ear, diencephalon, and notochord, that were not observed in the
BAC reporter line, suggesting that the regulatory elements controlling
these domains lie outside of the 180 kb of stickleback DNA included in
the BAC. Furthermore, while TALEN mutations severely reduced
expression in the ﬁns and teeth, every BAC reporter ﬁsh injected with
TALENs had GFP expression in the heart, suggesting that the enhancer
is not required for heart expression. Thus, the short enhancer
presented here contributes to a subset of the endogenous Bmp6
expression domains, with other domains likely driven by other
enhancers greater than 100 kb away. Evidence for long range distant
enhancers of stickleback Bmp6 is expected, given the frequent ﬁnding
of long distance regulatory elements for developmental regulatory
genes, including other vertebrate Bmp genes (reviewed in Pregizer and
Mortlock, 2009). Interestingly, despite the presence of redundant
“shadow” enhancers found in many genes (Calle-Mustienes et al.,
2005; Marinić et al., 2013; Perry et al., 2010), this enhancer appears to
be required for several Bmp6 expression domains; additional enhan-
cers did not appear to sufﬁciently compensate in driving Bmp6
expression when the 50 enhancer was targeted with TALENs.
Another teleost tooth/ﬁn enhancer has been described with
overall similar expression patterns observed in this Bmp6 enhan-
cer. In zebraﬁsh, an FGF-responsive enhancer mediates Dlx2
expression in teeth and median and pectoral ﬁns (Jackman and
Stock, 2006). Additionally, in mice, a Bmp4 enhancer drives tooth
epithelium and limb bud expression by responding to Pitx and
Msx homeodomains (Jumlongras et al., 2012). The shared ﬁn/limb
and tooth expression domains of these cis-regulatory elements
and the one described here suggest that ﬁn and tooth develop-
ment share multiple cis-regulatory networks, with at least three
signaling pathways (FGF, Pitx/Msx, and TGFß) involved in gener-
ating similar gene expression readouts in teeth and ﬁns/limbs.
Gene expression patterns of paired ﬁns are thought to be co-opted
from median ﬁn expression domains in agnathans (Freitas et al.,
2006). The Bmp6 enhancer presented here appears to be teleost-
speciﬁc, as we did not ﬁnd evidence of this conserved enhancer
sequence in the genomes of lamprey, elephant shark, or spotted
gar. Thus, our results suggest that teleosts may have secondarily
coopted components of a gene regulatory network in developing
median and pectoral ﬁns and teeth.
Elucidating the cis-regulatory architecture of stickleback Bmp6
and evolved changes in Bmp6's cis-regulatory architecture will
help test the hypothesis that evolved changes in Bmp6 cis-regula-
tion underlie the evolved increases in freshwater stickleback tooth
number we previously described (Cleves et al., 2014). Although the
190 bp core Bmp6 enhancer presented here contains no nucleotide
differences between low-toothed marine and high-toothed fresh-
water sticklebacks, several nucleotide differences exist in the
sequence ﬂanking the enhancer, which might contribute to the
cis-regulatory differences observed between marine and fresh-
water alleles of Bmp6. Future studies will focus on whether these
differences result in differential cis-regulatory activity between the
marine and freshwater alleles of Bmp6.
Conservation and turnover of cis- and trans-regulatory information
It has been proposed that the cis-regulatory architecture of
developmental control genes often consist of multiple independent
modules, each of which drives expression in a particular tissue or cell
Fig. 7. Treatment with TGFβ inhibitor SB431542 reduces Bmp6 expression. (A-D) Sticklebacks were treated with 100 μM SB431542 or vehicle control from 2 to 5 dpf or for
5 days post-hatching, and Bmp6 expression was assayed by in situ hybridization. Drug treatment severely reduced Bmp6 expression in ﬁns (A, B) and also reduced Bmp6
expression in tooth epithelia (C, D). Likewise, GFP driven by the Bmp6 locus in the reporter BAC was also reduced in ﬁns (arrowheads in E, F) and teeth (G, H) after SB431542
treatment. Scale bars¼100 μm.
P.A. Erickson et al. / Developmental Biology 401 (2015) 310–323320
type (Carroll, 2008; Stern, 2000). Because the Bmp6 enhancer drives
multiple anatomical expression domains and is only partially con-
served to zebraﬁsh, we hypothesized that domains may have been
sequentially added to the enhancer during teleost evolution, and that
the different anatomical domains would be separable. Contrary to
these predictions, our site directed mutagenesis and subcloning
experiments of the stickleback Bmp6 enhancer appeared to affect all
or none of the different expression domains, suggesting the different
anatomical domains might not be separable and instead reﬂect ability
to respond to a signal or signals present in multiple tissues.
Furthermore, enhancers from all four teleost species tested were
sufﬁcient to drive ﬁn and tooth expression in zebraﬁsh. However, the
zebraﬁsh enhancer, the most evolutionary divergent enhancer tested
in this study, did not function robustly in sticklebacks, suggesting that
the trans factors driving expression might have changed during the
divergence of the two species. Similarly, testing a zebraﬁsh Dlx2 tooth
and ﬁn enhancer in both zebraﬁsh and Mexican tetra revealed that
loss of oral Dlx2 expression in zebraﬁsh is caused by changes in trans
factors, as the Dlx2 zebraﬁsh tooth enhancer is active in tetra oral
teeth (Jackman and Stock, 2006). In both C. elegans and Drosophila,
transgenic testing of cis-regulatory elements from two ﬂy or worm
species in both ﬂy or worm species revealed that the greater the
evolutionary distance separating two regulatory elements, the more
likely upstream trans differences are to have evolved (Gordon and
Ruvinsky, 2012). But, subtle changes in trans-acting factors can
maintain similar expression patterns despite cis changes in divergent
lineages (Barrière et al., 2012). Our results suggest a combination of
conservation and divergence of trans factors, as stickleback sequence
worked robustly in zebraﬁsh, but zebraﬁsh sequence was not func-
tional in stickleback. Additionally, SB431542 treatment affected the
stickleback enhancer in zebraﬁsh more severely than in stickleback.
Even at a low dose of SB431542 (25 mM), the enhancer was completely
shut off in both epithelia and mesenchyme of zebraﬁsh teeth
(see Fig. 4E–F). This result supports potential trans regulatory diver-
gence between stickleback and zebraﬁsh, because it suggests that the
enhancer's expression may be more sensitive to TGFß signaling in
zebraﬁsh than in stickleback.
A role for TGFß in the regulation of BMPs
To our knowledge, this study is the ﬁrst to support a role for TGFβ
signaling in controlling Bmp signaling via a cis-regulatory input.
Conditional deletion of Tgfbr1 (Alk5) in mouse neural crest lineages
results in reduced expression of Bmp4 and delayed tooth initiation
(Zhao et al., 2008); however, the mechanism of this interaction has
not been described. Other studies have shown both positive and
negative correlations between Bmp6 expression and TGFβ levels:
Smad3 -/- chondrocytes have reduced Bmp6 expression (Li et al.,
2006), whereas Bmp6 expression is increased in Smad3 -/- tendons
undergoing tissue repair (Katzel et al., 2011). Our data suggest that in
sticklebacks, TGFß signaling activates Bmp6 expression in multiple
tissues via a predicted Smad3 binding site. In teeth, blocking TGFß
signaling using the inhibitor SB431542 caused loss of epithelial
reporter expression, but the effect on the mesenchymal expression
was less severe (Fig. 4C, Fig. 5). The same pattern was observed in
endogenous Bmp6 expression (Fig. 6O). This result suggests that
epithelial and mesenchymal Bmp6 expression domains respond to
partially different signaling pathways, with epithelial expressionmuch
more sensitive to TGFß disruption.
We observed that a higher dose of TGFβ inhibitor SB431542
was required to shut off endogenous Bmp6 expression relative to
expression driven solely by the 190 bp enhancer. While a 50 mM
treatment almost completely eliminated enhancer expression
(Fig. 4), at this dose we did not observe a strong difference in
GFP expression driven by the reporter BAC. Only at the higher dose
of 100 mM did we observe a change in BAC reporter expression and
endogenous Bmp6 expression (Fig. 7). This ﬁnding suggests that in
its native genomic context, the enhancer may be less sensitive to
TGFβ signaling perturbations than when it is isolated in a reporter
construct. There may be additional non-TGFβ regulatory elements
that drive Bmp6 expression in the same tooth and ﬁn domains
such that a decrease in TGFβ signaling has a less obvious effect at
lower doses. Furthermore, the effect of SB431542 treatment on
endogenous Bmp6 expression and BAC reporter expression was
not as dramatic as deletion of the Smad3 binding site with TALENs
(compare Fig. 6 to Fig. 7). This ﬁnding suggests that other non-
TGFß factors may bind sequences immediately surrounding the
Smad3 binding site to drive enhancer expression. However, the
predicted Smad3 site is absolutely required, as loss of this site
completely eliminates enhancer activity (Fig. 4J).
Combined effects of Wnt and TGFß on tooth development
Although our site-directed mutagenesis experiment indicated that
TCF/Lef predicted binding sites might be important for enhancer
function (Fig. 3), pharmacological testing with XAV939 did not
support the hypothesis that the enhancer requires Wnt signaling
inputs for enhancer function. A stable line of zebraﬁsh containing the
TCF/Lef mutated reporter also drove robust reporter expression in ﬁns
and teeth, providing a second piece of evidence that the enhancer
does not require Wnt input. This result was somewhat surprising, as
the expression domains driven by the Bmp6 enhancer are similar to a
TCF reporter zebraﬁsh line (Shimizu et al., 2012). The reduction in
activity seen frommutating the TCF/Lef sites may have been caused by
other unknown binding sites overlapping the mutated base pairs, by
inadvertently creating repressive motifs, or by somehow altering the
binding of the Smad3 complex. The mutations may have affected the
level, but not pattern, of GFP expression, making the construct appear
less robust in our transient transgenic assay. We did note that
combined treatment with XAV939 and SB431542 caused a slight
decrease in mesenchymal tooth GFP expression (see insets of Fig. 5),
however, this effect was less reproducible than the complete loss of
epithelial expression seen upon SB431542 treatment alone.
The combination treatment with SB431542 and XAV939 did
reduce tooth number in sticklebacks, suggesting that Wnt and
TGFβ signaling pathways together are required for maintaining
normal tooth development and patterning. In mice, as well as in
diphyodont humans and polyphyodonts including snakes and
alligators, Wnt signaling is required for tooth formation and
replacement (Adaimy et al., 2007; Bohring et al., 2009; Gaete
and Tucker, 2013; Genderen et al., 1994; Liu et al., 2008; Wu et al.,
2013). In mice, TGFß signaling is also required for tooth develop-
ment (Ferguson et al., 1998, 2001; Oka et al., 2007). Antisense
abrogation of both TGFB2 and TGFBRII in cultured mandibles
resulted in accelerated tooth formation (Chai et al., 1994, 1999),
however the TGFB2 knockout mouse has no reported tooth
phenotype (Sanford et al., 1997). While the TGFBRII knockout dies
prior to tooth formation (Oshima et al., 1996), conditional ablation
in neural crest cells prevents terminal differentiation of odonto-
blasts (Oka et al., 2007), while conditional ablation in Osx-expres-
sing odontoblasts revealed a necessary role for TGFBRII in molar
root development (Wang et al., 2013). Furthermore, Wnt and TGFß
signaling are required to activate Eda and Edar in appropriate
patterns in the developing tooth germs (Laurikkala et al., 2001).
However, to our knowledge, this study is the ﬁrst to show a
partially redundant requirement for TGFß and Wnt during tooth
development, as only XAV939 and SB431542 doubly treated ﬁsh
had reduced tooth numbers. Future studies of this enhancer will
further test the hypothesis that this enhancer responds to TGFß
signaling to control Bmp6 expression during tooth and ﬁn
development.
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Conclusions
We have identiﬁed a 190 base pair conserved enhancer required
for tooth, ﬁn, and other expression domains of stickleback Bmp6. Site
directed mutagenesis and pharmacology experiments support the
hypothesis that this enhancer responds to TGFß signaling via a Smad3
binding site. Expression driven by this enhancer in tooth epithelial
cells appears more sensitive to TGFß levels than expression in tooth
mesenchymal cells. To our knowledge, this is the ﬁrst demonstration
of a likely cis-regulatory link between TGFß signaling and Bmp
expression in teeth. In vivo deletion of this enhancer using TALENs
caused severe disruption of Bmp6 expression in ﬁns and tooth
epithelia, suggesting this enhancer is required for normal expression
patterns in a subset of Bmp6's endogenous domains. Finally, we
demonstrate that a combination of TGFß signaling and Wnt signaling
is required for normal tooth development in sticklebacks.
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